Cellebrite DI Ltd.
Символ: CLBT
NASDAQ
12.29
USDПазарна цена днес
-25.9174
Съотношение P/E
-0.0457
Коефициент PEG
2.43B
MRK Cap
- 0.00%
Доходност на DIV
Cellebrite DI Ltd. (CLBT) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1006.57 | 302.9 | 183.6 | 181.6 | |||||
balance-sheet.row.short-term-investments | 470.51 | 113.4 | 96 | 35.6 | |||||
balance-sheet.row.net-receivables | 277.62 | 77.3 | 78.8 | 67.5 | |||||
balance-sheet.row.inventory | 43.98 | 10.5 | 10.2 | 6.5 | |||||
balance-sheet.row.other-current-assets | 92.72 | 25.8 | 17.1 | 12.8 | |||||
balance-sheet.row.total-current-assets | 1438.53 | 416.5 | 295.9 | 273.2 | |||||
balance-sheet.row.property-plant-equipment-net | 120.14 | 30.2 | 32.9 | 16.8 | |||||
balance-sheet.row.goodwill | 107.32 | 26.8 | 26.8 | 26.8 | |||||
balance-sheet.row.intangible-assets | 41.83 | 10.6 | 11.3 | 11.2 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 149.14 | 37.4 | 38.1 | 38.1 | |||||
balance-sheet.row.long-term-investments | 74.17 | 28.9 | 22.1 | 0 | |||||
balance-sheet.row.tax-assets | 48.03 | 14.5 | 12.5 | 9.8 | |||||
balance-sheet.row.other-non-current-assets | 25.91 | 12.9 | 1.7 | 2 | |||||
balance-sheet.row.total-non-current-assets | 417.39 | 123.9 | 107.4 | 66.6 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 1855.92 | 540.4 | 403.3 | 339.8 | |||||
balance-sheet.row.account-payables | 26.18 | 8.3 | 4.6 | 9.5 | |||||
balance-sheet.row.short-term-debt | 19.35 | 5 | 5 | 0 | |||||
balance-sheet.row.tax-payables | 0.83 | 0.8 | 2.9 | 8.2 | |||||
balance-sheet.row.long-term-debt-total | 35.22 | 9.2 | 10.4 | -2.7 | |||||
Deferred Revenue Non Current | 190.55 | 47.1 | 42.2 | 36.4 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 94.12 | - | - | - | |||||
balance-sheet.row.other-current-liab | 160.29 | 44 | 45.5 | 54 | |||||
balance-sheet.row.total-non-current-liabilities | 836.94 | 252.4 | 121.7 | 226.6 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 49.59 | 9.2 | 15.4 | 0 | |||||
balance-sheet.row.total-liab | 1726.85 | 506.2 | 329.4 | 413.1 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 535.86 | 118.1 | 199.2 | 78.4 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.82 | 1.1 | 0.3 | 1.4 | |||||
balance-sheet.row.other-total-stockholders-equity | -407.62 | -85 | -125.7 | -153.2 | |||||
balance-sheet.row.total-stockholders-equity | 129.07 | 34.2 | 73.9 | -73.3 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1855.92 | 540.4 | 403.3 | 339.8 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 129.07 | 34.2 | 73.9 | -73.3 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 1855.92 | - | - | - | |||||
Total Investments | 544.68 | 142.3 | 118.1 | 35.6 | |||||
balance-sheet.row.total-debt | 54.56 | 14.1 | 15.4 | 0 | |||||
balance-sheet.row.net-debt | -481.49 | -175.4 | -72.3 | -146 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -81.1 | -81.1 | 120.8 | 71.4 | |||||
cash-flows.row.depreciation-and-amortization | 10.01 | 10 | 9.2 | 7.1 | |||||
cash-flows.row.deferred-income-tax | 5.13 | 5.1 | -2.4 | -1.6 | |||||
cash-flows.row.stock-based-compensation | 19 | 19 | 13.7 | 6.5 | |||||
cash-flows.row.change-in-working-capital | 38.52 | 38.5 | -2.8 | 20.6 | |||||
cash-flows.row.account-receivables | 2.27 | 2.3 | -12.9 | -2 | |||||
cash-flows.row.inventory | 0.24 | 0.2 | -3.7 | -1.8 | |||||
cash-flows.row.account-payables | 4.42 | 4.4 | -5.5 | 4.2 | |||||
cash-flows.row.other-working-capital | 31.58 | 31.6 | 19.2 | 20.2 | |||||
cash-flows.row.other-non-cash-items | 110.5 | 110.5 | -117.9 | -67.9 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 102.06 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | -7.92 | -7.9 | -9.1 | -8.1 | |||||
cash-flows.row.acquisitions-net | 24.78 | 0 | 106.6 | -20 | |||||
cash-flows.row.purchases-of-investments | -119.32 | -55.3 | -165.4 | -21 | |||||
cash-flows.row.sales-maturities-of-investments | 95.55 | 56.3 | 83.2 | 94.3 | |||||
cash-flows.row.other-investing-activites | -15.64 | -15.6 | -106.6 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | -22.54 | -22.5 | -91.2 | 45.2 | |||||
cash-flows.row.debt-repayment | -4.36 | -4.4 | 0 | 0 | |||||
cash-flows.row.common-stock-issued | 21.77 | 21.8 | 14 | 2.3 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -100 | |||||
cash-flows.row.other-financing-activites | 21.6 | 4.4 | 14 | 29.3 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 21.77 | 21.8 | 14 | -68.4 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.59 | 0.6 | -1.6 | -0.8 | |||||
cash-flows.row.net-change-in-cash | 101.87 | 101.9 | -58.3 | 12.1 | |||||
cash-flows.row.cash-at-end-of-period | 536.06 | 189.5 | 87.6 | 146 | |||||
cash-flows.row.cash-at-beginning-of-period | 434.19 | 87.6 | 146 | 133.8 | |||||
cash-flows.row.operating-cash-flow | 102.06 | 102.1 | 20.6 | 36.1 | |||||
cash-flows.row.capital-expenditure | -7.92 | -7.9 | -9.1 | -8.1 | |||||
cash-flows.row.free-cash-flow | 94.14 | 94.1 | 11.5 | 27.9 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 325.11 | 325.1 | 270.7 | 246.2 | |||||
income-statement-row.row.cost-of-revenue | 53.23 | 53.2 | 50.7 | 42.6 | |||||
income-statement-row.row.gross-profit | 271.88 | 271.9 | 219.9 | 203.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 84.39 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 43.44 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 110.81 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.operating-expenses | 238.64 | 238.6 | 218.9 | 189.9 | |||||
income-statement-row.row.cost-and-expenses | 291.87 | 291.8 | 269.6 | 232.4 | |||||
income-statement-row.row.interest-income | 60.72 | 10.7 | 1.6 | 68.5 | |||||
income-statement-row.row.interest-expense | 108.8 | 0.8 | 119.7 | 0.6 | |||||
income-statement-row.row.selling-and-marketing-expenses | 110.81 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | -108.8 | -108.8 | 119.7 | 68.5 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.total-operating-expenses | -108.8 | -108.8 | 119.7 | 68.5 | |||||
income-statement-row.row.interest-expense | 108.8 | 0.8 | 119.7 | 0.6 | |||||
income-statement-row.row.depreciation-and-amortization | 10.01 | 10 | 9.2 | 7.1 | |||||
income-statement-row.row.ebitda-caps | 43.25 | - | - | - | |||||
income-statement-row.row.operating-income | 33.24 | 33.3 | 1 | 13.8 | |||||
income-statement-row.row.income-before-tax | -75.56 | -75.6 | 120.8 | 82.3 | |||||
income-statement-row.row.income-tax-expense | 5.54 | 5.5 | 0 | 10.9 | |||||
income-statement-row.row.net-income | -81.1 | -81.1 | 120.8 | 71.4 |
Често задавани въпроси
Какво е Cellebrite DI Ltd. (CLBT) общи активи?
Cellebrite DI Ltd. (CLBT) общите активи са 540397000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 177192000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.484.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.484.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.249.
Какъв е общият приход на предприятието?
Общият приход е 0.102.
Каква е Cellebrite DI Ltd. (CLBT) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -81100000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 14129000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 238597000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 189517000.000.